Reassessing the minimum two-year follow-up standard after total shoulder arthroplasty-Is one year sufficient?
| Autor: | Mahendraraj KA; Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.; Boston Sports and Shoulder Center, Waltham, MA, USA., Carducci MP; Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.; Boston Sports and Shoulder Center, Waltham, MA, USA., Galvin JW; Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA., Golenbock SW; Department of Orthopaedic Research, New England Baptist, Boston, MA, USA., Grubhofer F; Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA., Jawa A; Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.; Boston Sports and Shoulder Center, Waltham, MA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Shoulder & elbow [Shoulder Elbow] 2021 Oct; Vol. 13 (5), pp. 527-533. Date of Electronic Publication: 2020 May 14. |
| DOI: | 10.1177/1758573220922845 |
| Abstrakt: | Background: US Food and Drug Administration Investigation Device Exemption studies and academic journals emphasize the importance of two-year follow-up data in reporting outcomes of total shoulder arthroplasty, but there is limited data evaluating appropriate follow-up length. We aim to evaluate change in postoperative outcomes and complications between one and two years following anatomic and reverse total shoulder arthroplasties. Methods: We retrospectively identified 250 patients who underwent anatomic and reverse total shoulder arthroplasties between 2013 and 2016 from a single surgeon arthroplasty registry. Patients without both one- and two-year follow-up data were excluded. We compared American Shoulder and Elbow Surgeons (ASES) score, Visual Analog Scale for pain, and goniometer-measured range of motion. Results: Patient-reported outcome measurements ( p > 0.05) did not change between one and two years postoperatively following both reverse ( n = 146) and anatomic ( n = 104) total shoulder arthroplasties. Range of motion increased slightly ( p < 0.05), but this change was not clinically relevant. There were no additional complications. Discussion: Minimum two-year clinical follow-up may not be necessary for future shoulder arthroplasty Investigation Device Exemption and other peer-reviewed investigations. Patient-reported outcomes (ASES and pain score) and range of motion plateau at one year postoperatively without additional complications. One-year follow-up is an acceptable minimum follow-up length. Level of Evidence: Level III-retrospective analysis. Competing Interests: Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Andrew Jawa has been a paid speaker and consultant for DJO Global, a paid consultant for Ignite Orthopedics, receives royalties from Depuy Synthesis, and has equity in Boston Outpatient Surgical Suites. (© 2020 The British Elbow & Shoulder Society.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|